A pharmaceutical study on improving the solubility of an antihypertensive drug /
Mohamed Ahmed Emad Abdellatif Elgendy
A pharmaceutical study on improving the solubility of an antihypertensive drug / دراسة صيدلة علي زيادة الذوبان لعقار مضاد لارتفاع ضغط الدم Mohamed Ahmed Emad Abdellatif Elgendy ; Supervised Omaima Naim Elgazayerly , Mina Ibrahim Tadros , Mona Ibrahim Abdeltawab Elassal - cairo : Mohamed Ahmed Emad Abdellatif El-Gendy , 2016 - 136 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Hypertension is a major health problem worldwide, yet remains under- diagnosed and under-treated, it is also considered as the most prevalent and powerful contributor for cardiovascular (CV) diseases worldwide. It is mostly accompanied with other risk factors such as dyslipidaemia, insulin resistance, glucose intolerance and obesity. CV diseases lead to serious events such as myocardial infarction and stroke which has been labelled as the most important hypertension related complication which contributes to the premature death of millions of people each year. The primary goal of hypertension management is to achieve the maximum reduction in the long-term total risk of cardiovascular morbidity and mortality
Mixed micelles Olmesartan Medoxomil Oral bioavailability
A pharmaceutical study on improving the solubility of an antihypertensive drug / دراسة صيدلة علي زيادة الذوبان لعقار مضاد لارتفاع ضغط الدم Mohamed Ahmed Emad Abdellatif Elgendy ; Supervised Omaima Naim Elgazayerly , Mina Ibrahim Tadros , Mona Ibrahim Abdeltawab Elassal - cairo : Mohamed Ahmed Emad Abdellatif El-Gendy , 2016 - 136 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Hypertension is a major health problem worldwide, yet remains under- diagnosed and under-treated, it is also considered as the most prevalent and powerful contributor for cardiovascular (CV) diseases worldwide. It is mostly accompanied with other risk factors such as dyslipidaemia, insulin resistance, glucose intolerance and obesity. CV diseases lead to serious events such as myocardial infarction and stroke which has been labelled as the most important hypertension related complication which contributes to the premature death of millions of people each year. The primary goal of hypertension management is to achieve the maximum reduction in the long-term total risk of cardiovascular morbidity and mortality
Mixed micelles Olmesartan Medoxomil Oral bioavailability